Piotr Laskowski

Dr. Piotr Laskowski

University of Bialystok
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
PSPaweł Sowa
Paweł Sowa
ŁKŁukasz Kiszkiel
Łukasz Kiszkiel
Piotr LaskowskiPiotr Laskowski
Piotr Laskowski
Maciej AlimowskiMaciej Alimowski
Maciej Alimowski
LSLukasz Szczerbinski
Lukasz Szczerbinski
Karol Adam KaminskiKarol Adam Kaminski
Karol Adam Kaminski
Since the declaration of the SARS-CoV-2 pandemic confirmed by World Health Organization, work on the development of vaccines has been stimulated. When vaccines are commonly available, a major problem is persistent vaccine hesitancy in many European countries. The main goal of our study was to understand the multidimensional factors inducing this phenomenon in Poland. Our study was carried out at the third wave’s peak of the pandemic, with record rates of daily cases and deaths associated with COVID-19. The results indicate that vaccine hesitancy/acceptability should always be considered in an interdisciplinary manner and according to identified factors where most negative attitudes could be altered. Our analyses included the assessment of a representative quota sample of adult Poles (N = 1000). The vaccine hesitancy in the studied group reached 49.2%. We performed stepwise logistic regression modeling to analyze variables set into six trajectories (groups) predicting the willingness to vaccinate. Apart from typical, socio-demographic and economic determinants, we identified the fear of vaccines’ side effects, beliefs in conspiracy theories and physical fitness. We were also able to establish the order of importance of factors used in a full model of all impact trajectories.

SSSebastian Adam Sołomacha
Sebastian Adam Sołomacha
PSPaweł Sowa
Paweł Sowa
ŁKŁukasz Kiszkiel
Łukasz Kiszkiel
Piotr LaskowskiPiotr Laskowski
Piotr Laskowski
Maciej AlimowskiMaciej Alimowski
Maciej Alimowski
Karol Adam KaminskiKarol Adam Kaminski
Karol Adam Kaminski
The outbreak of the COVID-19 pandemic caused the healthcare system to drastically reduce in-person visits and suddenly switch to telemedicine services to provide clinical care to patients. The implementation of teleconsultation in medical facilities was a novelty for most Polish patients. In Poland, the main telehealth services were provided in the form of telephone consultations. The aim of this study is to determine patients’ perceptions of telemedicine in the context of their experiences with the healthcare system during the COVID-19 pandemic. In this study, we presented how the evaluation of telemedicine services from the perspective of patients in Poland changed in the context of the ongoing pandemic. We conducted two surveys (year by year) on a representative quota sample of the Polish population (N = 623). This ensured that our observations took into account the evolution of views on telemedicine over time. We confirmed the well-known relationship that innovations introduced in the healthcare sector require a longer period of adaptation. We also identified significant concerns that limit the positive perception of telemedicine and compared them with experiences described in other countries.

5 March 2024 in Religion, Brain & Behavior
Verified
Journal Article
Open access
ŁKŁukasz Kiszkiel
Łukasz Kiszkiel
Piotr LaskowskiPiotr Laskowski
Piotr Laskowski
DVDavid Voas
David Voas
RBRachel J. Bacon
Rachel J. Bacon
Wesley WildmanWesley Wildman
Wesley Wildman
KTKonrad Talmont-Kamiński
Konrad Talmont-Kamiński

27 June 2017 in Studies in Logic, Grammar and Rhetoric
Verified
Journal Article
Open access
PDF file
Piotr LaskowskiPiotr Laskowski
Piotr Laskowski
The article describes selected issues related to user safety on the Internet. This safety consists of a number of factors such as the technology that we use to communicate and to browse the Internet, and habits and behaviors that we have acquired and through which we can identify at least some typical hazards encountered on the Web. Knowledge of software and the ability to use it and to configure it properly as well as checking regularly for security updates reduces the risk of data loss or identity theft. Public awareness of threats continues to grow, but there are also new, previously unknown threats; that is why it is so important to inform of the dangers by all available channels of communication.

15 March 2025 in Advances in Medical Sciences
Verified
Journal Article
Open access
JAJustyna Adamczuk
Justyna Adamczuk
Karol Adam KaminskiKarol Adam Kaminski
Karol Adam Kaminski
SSSebastian Adam Sołomacha
Sebastian Adam Sołomacha
MKMałgorzata Kazberuk
Małgorzata Kazberuk
MCMagdalena Chlabicz
Magdalena Chlabicz
Anna Moniuszko-MalinowskaAnna Moniuszko-Malinowska
Anna Moniuszko-Malinowska
In the present study, we aimed to assess the anti-SARS-CoV-2 antibodies in population or in convalescents 6 months after infection with COVID-19. The study population consisted of 2 groups, i.e. group I: 232 post-COVID-19 patients, and group II: 544 patients from a population cohort. Detection of anti-N antibodies was performed with Elecsys Anti-SARS-CoV-2 and anti-S antibodies with LIAISON SARS-CoV-2 S1/S2 IgG tests. After the Omicron wave, gradual increase in the prevalence of the analyzed antibodies was observed in the general population - up to 92.5% of anti-S and 69.7% of anti-N antibodies. In the COVID-19 convalescents, 6 months after infection, 4.3% and 3.7% did not generate significant titer of anti-S and anti-N antibodies, respectively. Among patients, who were vaccinated, 1% did not generate anti-S antibodies. Median age of those who did not respond was higher than those who responded. Sex did not influence the results. Comparison of anti-N and anti-S antibodies 6 months after infection in the whole group showed higher anti-N titer in patients who suffered from the disease than in the general population. In the general population, 17.4% of participants had anti-N antibodies, and 9% had anti-S antibodies, despite no prior vaccination or history of COVID-19. High prevalence of anti-N antibodies in patients reporting no history of COVID-19 during last wave, even after official end of the pandemics suggests high prevalence of SARS-CoV-2 in the environment and frequent asymptomatic or unspecific COVID-19, what is of high importance from the public health perspective.

29 April 2025 in Medicina
Verified
Journal Article
Open access
PDF file
KGKatarzyna Guziejko
Katarzyna Guziejko
Anna Moniuszko-MalinowskaAnna Moniuszko-Malinowska
Anna Moniuszko-Malinowska
Robert FlisiakRobert Flisiak
Robert Flisiak
PCPiotr Czupryna
Piotr Czupryna
SSSebastian Sołomacha
Sebastian Sołomacha
Karol Adam KaminskiKarol Adam Kaminski
Karol Adam Kaminski
Background: Despite the multiple waves of the COVID-19 pandemic, follow-up strategies for recovered patients remain inconclusive. This study aimed to evaluate chest computed tomography (CT) and pulmonary function test (PFT) abnormalities in convalescents six months after COVID-19 and to compare these findings with those from a representative population cohort. The goal was to support more individualized pulmonary management of post-COVID-19 sequelae. Methods: This study population consisted of 2 groups: I—232 post-COVID-19 patients and II—543 patients from a population cohort. Chest CT was performed during the acute phase of COVID-19 and six months after. The PFTs were conducted six months after COVID-19. Results: There were no significant differences in FEV1, FVC, TLC, and DLCO in the two study groups. A singular GGO in 24 patients (20%), a crazy paving pattern in 1 patient (0.8%), thickening of interlobular septa in 4 patients (3.5%), consolidations in 4 patients (3.5%), traction bronchiectasis in 6 patients (5%), fibrosis in 6 patients (5%), and singular nodular densities in 68 patients (58%) were observed in chest CT 6 months after COVID-19. Most radiological abnormalities were clinically insignificant and did not require further diagnostic evaluation. No significant differences in chest CT and PFT six months after infection were observed between patients differing in the severity of inflammation during the acute disease or SARS-CoV-2 variant. Conclusions: The majority of chest CT abnormalities resolved within six months of recovery, regardless of SARS-CoV-2 variant or initial disease severity. Pulmonary function tests should be prioritized in post-COVID-19 follow-up, as PFT results in convalescents were comparable to those observed in the general population.